PURE BIOSCIENCE, INC.
For the period ended Apr 30, 2026. Filed Jun 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 30, 2026 · Filed Jun 15, 2026
PUREStored price and day change unavailable
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-01-31; filed 2026-03-17.
0001493152-26-010385
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresOther InformationCurrent report: 10-Q
Period ended 2026-04-30; filed 2026-06-15.
0001493152-26-028691
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 10 previous paragraphs and 23 current paragraphs.
7 unchanged; 2 reworded; 14 added; 1 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (14)
Current report
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Current report
Item 3. Defaults Upon Senior Securities
Current report
On June 15, 2026, PURE Bioscience, Inc. (the “Company”) announced that Robert Bartlett would be retiring from his role as the Company’s Chief Executive Officer, effective August 1, 2026 (the “Transition Date”). Following the Transition Date, Mr. Bartlett will continue in his role as a member of the Company’s Board of Directors (the “Board”) and will act as an advisor to the next Chief Executive Officer. The Company also announced the promotion of Jeffrey Kitchell from his current role as the Company’s President to the Company’s Chief Executive Officer and the appointment of Mr. Kitchell to the Board, in each case, to be effective the Transition Date. The Board approved the Transition and Mr. Kitchell’s promotion and appointment to the Board on June 11, 2026.
Current report
Mr. Kitchell, 55, has served as the Company’s President since November 2025. He also serves as the Company’s Corporate Secretary, a role he has had since 2019. Mr. Kitchell oversees day-to-day operations, supports the Company’s functions, and implements new structures and processes. Prior to serving as the Company’s President, Mr. Kitchell served as the Company’s Vice President of Operations from April 2023 to November 2025. In addition, Mr. Kitchell has held various other roles since joining the Company in 2001. In these various roles, he managed the Company’s legal affairs and helped secure its intellectual property. Before joining the Company, Mr. Kitchell held various leadership roles in companies ranging from small to large. Mr. Kitchell earned a Bachelor’s Degree in Business Administration from the University of Phoenix.
Current report
The Company expects to enter into an employment agreement with Mr. Kitchell in connection with his promotion to the position of Chief Executive Officer, and once the terms of such agreement are finalized, the Company will file a Current Report on Form 8-K to report the required information within four business days after such information is determined or becomes available.
Current report
Except as set forth above, there are no arrangements or understandings between Mr. Kitchell and any other persons pursuant to which he was named to this position with the Company or appointed as a director. There are no family relationships between Mr. Kitchell and any of the Company’s directors or executive officers or any persons nominated or chosen by the Company to be a director or executive officer. Additionally, Mr. Kitchell does not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Current report
On June 15, 2026, the Company also announced that Bernard Blotner resigned as a member of the Board and any committees of the Board, effective June 11, 2026. The resignation was not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Current report
(c) Securities Trading Plans of Directors and Executive Officers
Current report
During the quarter ended April 30, 2026, none of our officers or directors, as defined in Rule 16a-1(f), informed us of theadoption ortermination of a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement, each as defined in Regulation S-K Item 408.
Removed paragraphs (1)
Reworded paragraphs (2)
Previous wording
In evaluating us and our common stock, we urge you to carefully consider the risks and other information in this Quarterly Report on Form 10-Q, including the risk factor included below, as well as the risk factors disclosed in Item 1A. to Part I of our Annual Report on Form 10-K for the fiscal year ended July 31, 2025, which we filed with the SEC on October 29, 2025 (the “Form 10-K”). Other than the risk factor included below, the risks and uncertainties described in “Item 1A — Risk Factors” of our Form 10-K have not materially changed. Any of the risks discussed in this Quarterly Report on Form 10-Q, including the risk factor included below, or any of the risks disclosed in “Item 1A — Risk Factors” of our Form 10-K, as well as additional risks and uncertainties not currently known to us or that we currently deem immaterial, could materially and adversely affect our results of operations, financial condition or prospects.
Current wording
In evaluating us and our common stock, we urge you to carefully consider the risks and other information in this Quarterly Report on Form 10-Q, including the risk factor included below, as well as the risk factors disclosed in Item 1A. to Part I of our Annual Report on Form 10-K for the fiscal year ended July 31, 2025, which we filed with the SEC on October 29, 2025, or the Form 10-K. Other than the risk factor included below, the risks and uncertainties described in “Item 1A — Risk Factors” of our Form 10-K have not materially changed. Any of the risks discussed in this Quarterly Report on Form 10-Q, including the risk factor included below, or any of the risks disclosed in “Item 1A — Risk Factors” of our Form 10-K, as well as additional risks and uncertainties not currently known to us or that we currently deem immaterial, could materially and adversely affect our results of operations, financial condition or prospects.
Previous wording
We have a history of recurring losses, and as of January 31, 2026 we have incurred a cumulative net loss of $140,243,000. During the six months ended January 31, 2026, we recorded a net loss of $1,249,000 on recorded net revenue of $1,152,000. In addition, during the six months ended January 31, 206 we used $856,000 in operating activities resulting in a cash balance of $198,000 as of January 31, 2026. As a result, our existing cash resources are not sufficient to meet our anticipated needs over the next twelve months from the date hereof, and we will need to raise additional capital to continue our operations and to implement our business plan, which capital may not be available on acceptable terms or at all.
Current wording
We have a history of recurring losses, and as of April 30, 2026 we have a stockholder deficiency of $5,839,000. During the nine months ended April 30, 2026, we recorded a net loss of $1,873,000 on recorded net revenue of $1,658,000. In addition, during the nine months ended April 30, 2026, we used $1,324,000 in operating activities resulting in a cash balance of $983,000 as of April 30, 2026. As a result, our existing cash resources are not sufficient to meet our anticipated needs over the next twelve months from the date hereof, and we will need to raise additional capital to continue our operations and to implement our business plan, which capital may not be available on acceptable terms or at all.